PMID- 22222238
OWN - NLM
STAT- MEDLINE
DCOM- 20121106
LR  - 20220317
IS  - 1526-4637 (Electronic)
IS  - 1526-2375 (Linking)
VI  - 13
IP  - 2
DP  - 2012 Feb
TI  - The effects of coexisting fibromyalgia syndrome on pain intensity, disability, 
      and treatment outcome in patients with chronic lateral epicondylitis.
PG  - 270-80
LID - 10.1111/j.1526-4637.2011.01300.x [doi]
AB  - OBJECTIVE: The objective of this study was to evaluate the effects of coexisting 
      fibromyalgia syndrome (FS) on pain intensity, disability, and treatment outcome 
      in patients with chronic lateral epicondylitis (LE). METHODS: Seventy-eight 
      patients with chronic unilateral LE and 30 healthy subjects were included. 
      Patients were classified into two groups: group 1 consisted of 46 LE alone 
      patients, while group 2 consisted of 32 LE plus FS patients. A pain questionnaire 
      was used to determine the subjective pain and disability. Pressure pain threshold 
      (PPT) on the lateral epicondyles, isometric hand grip strength (IHGS), lateral 
      pinch grip strength (LPGS), and tender point examinations of groups were 
      performed. A mixture of methylprednisolone and prilocaine was injected 1 cm 
      distal to the lateral epicondyle. All measurements were repeated 2 weeks and 3 
      months after injection. RESULTS: Compared with healthy subjects, both patient 
      groups had significantly increased pain and disability scores and decreased IHGS, 
      LPGS, and PPT values (P < 0.001). Compared with the LE alone group, pain and 
      disability scores were significantly higher (P < 0.01), and PPT, IHGS, and LPGS 
      values were significantly lower in LE plus FS group (P < 0.05). Pain 
      questionnaire scores of the LE alone and LE plus FS patients showed statistically 
      significant decrease, and IHGS, LPGS, and PPTs showed statistically significant 
      increase at the second week (P < 0.01) and at the third month (P < 0.001) after 
      injection. Improvements in the LE plus FS group were poorer than FS alone group 
      at both second week and third month after injection. CONCLUSION: Coexisting FS 
      may increase the pain intensity and disability, and negatively affect the 
      treatment outcome in patients with chronic LE.
CI  - Wiley Periodicals, Inc.
FAU - Genc, Hakan
AU  - Genc H
AD  - 2nd Department of Physical Medicine and Rehabilitation, Ministry of Health, 
      Ankara Training and Research Hospital, Ankara, Turkey. hakangenc06@hotmail.com
FAU - Nacir, Baris
AU  - Nacir B
FAU - Duyur Cakit, Burcu
AU  - Duyur Cakit B
FAU - Saracoglu, Meryem
AU  - Saracoglu M
FAU - Erdem, Hatice R
AU  - Erdem HR
LA  - eng
PT  - Journal Article
DEP - 20120105
PL  - England
TA  - Pain Med
JT  - Pain medicine (Malden, Mass.)
JID - 100894201
SB  - IM
CIN - Pain Med. 2012 Jun;13(6):848. PMID: 22494401
MH  - Adult
MH  - Comorbidity/trends
MH  - Disability Evaluation
MH  - Female
MH  - Fibromyalgia/*diagnosis/drug therapy/*epidemiology
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Pain Measurement/methods
MH  - Surveys and Questionnaires/standards
MH  - Tennis Elbow/*diagnosis/drug therapy/*epidemiology
MH  - Treatment Outcome
EDAT- 2012/01/10 06:00
MHDA- 2012/11/07 06:00
CRDT- 2012/01/07 06:00
PHST- 2012/01/07 06:00 [entrez]
PHST- 2012/01/10 06:00 [pubmed]
PHST- 2012/11/07 06:00 [medline]
AID - 10.1111/j.1526-4637.2011.01300.x [doi]
PST - ppublish
SO  - Pain Med. 2012 Feb;13(2):270-80. doi: 10.1111/j.1526-4637.2011.01300.x. Epub 2012 
      Jan 5.